# FDA Inspection 1293102 - Apertus Pharmaceuticals - October 31, 2025

Source: https://www.globalkeysolutions.net/records/fda_inspections/apertus-pharmaceuticals/4d73ddf6-e997-437e-ac7a-149451922bf0
Source feed: FDA_Inspections

> FDA Inspection 1293102 for Apertus Pharmaceuticals on October 31, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1293102
- Company Name: Apertus Pharmaceuticals
- Inspection Date: 2025-10-31
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1293102 - 2025-10-31](https://www.globalkeysolutions.net/records/fda_inspections/apertus-pharmaceuticals/d2159b71-ad5c-474a-a568-a403b00cb157)
- [FDA Inspection 1119160 - 2020-01-16](https://www.globalkeysolutions.net/records/fda_inspections/apertus-pharmaceuticals/69ebf067-fc54-434c-b431-ecc838356afd)

Company: https://www.globalkeysolutions.net/companies/apertus-pharmaceuticals/7436af25-9f52-43d1-a68e-002922496155

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c